Comparing the Efficacy of Hybrid, High-dose Dual and Bismuth Quadruple Therapies

NCT03779074 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

918

Enrollment

OTHER

Sponsor class

Conditions

Helicobacter Pylori Infection

Interventions

DRUG: 10d bismuth quadruple therapy
DRUG: 14d hybrid therapy
DRUG: 14D high-dose dual therapy

Sponsor

Kaohsiung Veterans General Hospital.